This chart lists the major biomedical research reporting guidelines that provide advice for reporting research methods and findings. They usually "specify a minimum set of items required for a clear and transparent account of what was done and what was found in a research study, reflecting, in particular, issues that might introduce bias into the research" Adapted from the EQUATOR Network Resource Centre. The chart also includes editorial style guides for writing research reports or other publications. See the details of the search strategy. For reporting animal research and peer-reviewers of animal research studies.
Results and reporting
Results and reporting | Investors | Home
This page deals with the central part of the thesis, where you present the data that forms the basis of your investigation, shaped by the way you have thought about it. In other words, you tell your readers the story that has emerged from your findings. The form of your chapters should be consistent with this story and its components. For many kinds of research, the main work of interpretation cannot be done until most of the data has been collected and analysed. Whatever kind of research you are doing, there comes a moment when your head is full of ideas that have emerged from your analysis. Ideally, you will have written them down as they came to you. Now you have to convert that mass of material and ideas into a written text that will make sense to a reader, and do justice to your findings.
Survey data analysis: Best practices, helpful tips, and our favorite tools
Published on December 21, by Pritha Bhandari. Revised on April 1, The results section of a quantitative research paper is where you summarize your data and report the findings of any relevant statistical analyses.
There is currently significant attention to the distribution of final study data and results, both to the subjects who participated in the research and to the public at large. SACHRP has determined that there are four aspects of returning research results to subjects and releasing the results publicly, with overlap of the concepts along a spectrum:. SACHRP partially addressed the issue of public release of data in December of by providing commentary in response to the June 4, , Food and Drug Administration FDA Request for Comment relating to the availability of masked and de-identified non-summary safety and efficacy data.